KNG1 Antibody

KNG1

Alpha-2-thiol proteinase inhibitor antibody; BDK antibody; BK antibody; Bradykinin antibody; Bradykinin included antibody; Fitzgerald factor antibody; FLAUJEAC FACTOR antibody; High molecular weight kininogen antibody; HMWK antibody; Ile-Ser-Bradykinin antibody; Kallidin I antibody; Kallidin II antibody; KNG antibody; KNG1 antibody; KNG1_HUMAN antibody; Low molecular weight growth-promoting factor antibody; WILLIAMS FACTOR antibody; Williams-Fitzgerald-Flaujeac factor antibody

Recombinant Human Kininogen-1 protein (390-644AA)

Kininogens are inhibitors of thiol proteases, (2) HMW-kininogen plays an important role in blood coagulation by helping to position optimally prekallikrein and factor XI next to factor XII, (3) HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes, (4) the active peptide bradykinin that is released from HMW-kininogen shows a variety of physiological effects: (4A) influence in smooth muscle contraction, (4B) induction of hypotension, (4C) natriuresis and diuresis, (4D) decrease in blood glucose level, (4E) it is a mediator of inflammation and causes (4E1) increase in vascular permeability, (4E2) stimulation of nociceptors (4E3) release of other mediators of inflammation (e.g. prostaglandins), (4F) it has a cardioprotective effect (directly via bradykinin action, indirectly via endothelium-derived relaxing factor action), (5) LMW-kininogen inhibits the aggregation of thrombocytes, (6) LMW-kininogen is in contrast to HMW-kininogen not involved in blood clotting.

>95%, Protein G purified

Cardiovascular

Recombinant Human Kininogen-1 protein (390-644AA)